Institutional Manager · CIK 0001920938
BRAIDWELL LP
STAMFORD, CT · File #028-23075
Latest AUM
$3.13B
Positions
73
Top-10 Concentration
41.5%
Filings
9
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| REDUCE | GUARDANT HEALTH INC | GH | -114,600,000 | -$210.2M | +$116.2M |
| EXITED | NOVOCURE LTD | 67011XAB9 | -211,364,000 | -$210.0M | $0 |
| REDUCE | XENON PHARMACEUTICALS INC | XENE | -1,779,953 | -$79.8M | +$16.8M |
| REDUCE | KRYSTAL BIOTECH INC | KRYS | -318,300 | -$78.5M | +$36.4M |
| REDUCE | APOGEE THERAPEUTICS INC | APGE | -863,678 | -$65.2M | +$51.4M |
| REDUCE | CG ONCOLOGY INC | CGON | -1,412,746 | -$58.7M | +$4.1M |
| NEW | KODIAK SCIENCES INC | KOD | +2,072,788 | +$58.0M | $0 |
| NEW | CENTESSA PHARMACEUTICALS PLC | CNTA | +2,188,320 | +$54.7M | $0 |
| NEW | BRIGHTSPRING HEALTH SVCS INC | 10950A106 | +1,195,786 | +$44.8M | $0 |
| REDUCE | DANAHER CORPORATION | 235851102 | -191,112 | -$43.7M | +$9.5M |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202573 pos · $3.13B
- 13F HOLDINGS REPORTQ/E Sep 202573 pos · $3.37B
- 13F HOLDINGS REPORTQ/E Jun 202555 pos · $2.92B
- 13F HOLDINGS REPORTQ/E Mar 202564 pos · $2.84B
- 13F HOLDINGS REPORTQ/E Dec 202473 pos · $3.86B
- 13F HOLDINGS REPORTQ/E Sep 202481 pos · $3.53B
- 13F HOLDINGS REPORTQ/E Jun 202475 pos · $3.19B
- 13F HOLDINGS REPORTQ/E Mar 202470 pos · $3.10B
- 13F HOLDINGS REPORTQ/E Dec 202386 pos · $3.16B
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | CARIS LIFE SCIENCES INC | CAI | 7,816,142 | $210.9M | 7.38% |
| 2 | GUARDANT HEALTH INC | GH | 104,854,000 | $192.3M | 6.73% |
| 3 | EDGEWISE THERAPEUTICS INC | EWTX | 5,210,831 | $129.3M | 4.53% |
| 4 | REPLIGEN CORP | RGEN | 101,000,000 | $110.8M | 3.88% |
| 5 | NEUROCRINE BIOSCIENCES INC | NBIX | 751,534 | $106.6M | 3.73% |
| 6 | GLAUKOS CORP | GKOS | 921,979 | $104.1M | 3.65% |
| 7 | NEOGENOMICS INC | NEO | 100,381,000 | $89.7M | 3.14% |
| 8 | NUVALENT INC | NUVL | 821,406 | $82.6M | 2.89% |
| 9 | XENON PHARMACEUTICALS INC | XENE | 1,825,076 | $81.8M | 2.86% |
| 10 | CG ONCOLOGY INC | CGON | 1,870,571 | $77.7M | 2.72% |
| 11 | IRHYTHM TECHNOLOGIES INC | IRTC | 52,000,000 | $72.8M | 2.55% |
| 12 | HINGE HEALTH INC | HNGE | 1,304,623 | $60.6M | 2.12% |
| 13 | ALIGN TECHNOLOGY INC | ALGN | 381,004 | $59.5M | 2.08% |
| 14 | KODIAK SCIENCES INC | KOD | 2,072,788 | $58.0M | 2.03% |
| 15 | SOLENO THERAPEUTICS INC | SLNO | 1,187,859 | $55.0M | 1.93% |
| 16 | CENTESSA PHARMACEUTICALS PLC | CNTA | 2,188,320 | $54.7M | 1.92% |
| 17 | NEOGENOMICS INC | NEO | 4,632,801 | $54.5M | 1.91% |
| 18 | ACADIA PHARMACEUTICALS INC | ACAD | 2,032,021 | $54.3M | 1.90% |
| 19 | SPYRE THERAPEUTICS INC | SYRE | 1,634,615 | $53.5M | 1.88% |
| 20 | DIANTHUS THERAPEUTICS INC | DNTH | 1,273,935 | $52.5M | 1.84% |